Lifetime Risk of Developing or Dying From Cancer
Learn about the chance each person has of being diagnosed with or dying from different types of cancer during his or her lifetime.
Learn about the chance each person has of being diagnosed with or dying from different types of cancer during his or her lifetime.
People may be able to wait longer between colonoscopies, and a trial evaluates a less invasive option for treating prostate cancer.
This award recognizes an investigator whose novel and significant work has had or may have a far-reaching impact on the etiology, detection, diagnosis, treatment or…
Presented by The Rivkin Center for Ovarian Cancer and the AACR September 20-21, 2024Seattle Airport Marriott HotelSeattle, Washington Symposium Cochairs Joyce F. Liu, Dana-Farber Cancer…
AACR Project GENIE is a public cancer registry of real-world data available for use in genomics projects to power precision medicine.
AACR members at the AACR Annual Meeting 2023. The AACR’s mission to prevent and cure all cancers is driven by its members. AACR member scientists,…
This award recognizes outstanding science that has inspired new perspectives on the etiology, diagnosis, treatment, or prevention of breast cancer.
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
The Texas dairy worker infected by H5N1 “did not disclose the name of their workplace,” frustrating investigators.
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…
FDA-AACR Workshop: How Much is Enough? Trial Designs for Treatment Regimens with Multiple Phases Date: May 9, 2024 | 9:00 a.m. – 4:00 p.m. Location:…